Foresite Capital
San Francisco, Californiaforesitecapital.com
Overview
Foresite Capital is a multi-stage healthcare and life sciences investment firm that uses a data science-driven approach to invest in companies at the intersection of technology and biotechnology across their full lifecycle.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Remix Therapeutics | Jun 2026 | M&A | Co-investor |
| Quince Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Stepful | Jun 2026 | Series C | Co-investor |
| Avenzo Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
Key People
Cynthia Carpenter
Executive Associate to CEO and Founder, Jim Tananbaum
Jim Tananbaum
Founder And CEO
Cindy Xiong
Partner
Hyung Chun
Partner
Lovely Rose E.
Partner
Travis Young
Partner
Beata Lewandowska
Vice President Partner
Ekaterina K
Partner Deep Tech Ventures Board Member
Deepak S. Atri
Principal
Shoman Kasbekar
Principal
Matt Dyer 🇺🇦
Executive Advisor Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
